Prosensa Therapeutics B.V.
Prosensa engages in the development and commercialization of ribonucleic acid modulating therapeutics.
Business Model:
Revenue: $12.3M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Prosensa Therapeutics B.V. Information
Prosensa Therapeutics B.V. was acquired by
BioMarin Pharmaceutical.
The acquisition happend on 2014-11-24.
Details of the transaction were not public
Acquirer
Geographic Data
Address: J.H. Oortweg 21
City: Leiden
State: other
Zip: 2333-CH
Country: NL
Financial Info
Stage:
grant
Raised Last:
$200k
Raised Total:$55M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Prosensa engages in the development and commercialization of ribonucleic acid modulating therapeutics.
Contact Phone:
Contact Email:
Prosensa Therapeutics B.V. went public on 6/27/2013 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
6/27/2013
Ticker Symbol:
RNA
IPO Price:
$13/share
Amount Raised:
$260M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 1/2012 | Prosensa | Venture Round | 30M |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
